Skip to content

13F-HR filed by ALPS ADVISORS INC

ALPS ADVISORS INC filed this 13F-HR for the quarter ended 2022-09-30, filed 2022-11-14, with 1,040 holding rows worth $10,568,887,000.

Accession
0001398344-22-021967
Filed
2022-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2022

A combination report, 1,126 entries on the cover page, a total value of $10,568,887,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $10,568,902,000 with VALUE read as thousands by filing date, 13F file number 028-12230. The quarter's positions are built on this report. The resolved quarter.

Other managers

  • reports for this filerAristotle Capital Management, LLC 028-02634
  • reports for this filerCongress Asset Management Co. 028-03434
  • reports for this filerCoreCommodity Management, LLC 028-11239
  • reports for this filerFiduciary Management, Inc. 028-01526
  • reports for this filerGSI Capital Advisors, LLC 028-12448
  • reports for this filerHillman Capital Management, Inc. 028-11091
  • reports for this filerPrincipal Financial Group, Inc. 028-10106
  • reports for this filerPrincipal Real Estate Investors LLC 028-10400
  • reports for this filerPzena Investment Management 028-03791
  • reports for this filerRiverFront Investment Group 028-13577
  • reports for this filerSustainable Growth Advisers, LP 028-11076
  • reports for this filerTCW Group, Inc. 028-02494
  • reports for this filerTCW Investment Management Co. 028-06683
  • reports for this filerWeatherbie Capital, LLC 028-04129
  • included managerRed Rocks Capital LLC 028-14056
  • included managerMorningstar Investment Management LLC 028-17446
  • included managerRiverFront Investment Group, LLC 028-13577
  • included managerSprott Asset Management LP 028-14703

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
ALBIREO PHARMA INC01345P106COMMON STOCK10,748$208,000thousands by filing date
CENTESSA PHARMACEUTICALS PLC152309100SPONSORED ADS51,503$207,000thousands by filing date
O-I GLASS INC67098H104COM15,336$199,000thousands by filing date
KALVISTA PHARMACEUTICALS INC483497103COM13,433$195,000thousands by filing date
IDENTIV INC45170X205COM NEW14,995$188,000thousands by filing date
ADC THERAPEUTICS SAH0036K147COMMON STOCK38,571$186,000thousands by filing date
INVIVYD INC00534A102COMMON STOCK59,405$186,000thousands by filing date
NOVABRIDGE BIOSCIENCES44975P103CMN45,137$181,000thousands by filing date
BIOXCEL THERAPEUTICS INC09075P105COM15,246$180,000thousands by filing date
MIMEDX GROUP INC602496101COM62,007$178,000thousands by filing date
CONCERT PHARMACEUTICALS INC206022105COM26,197$176,000thousands by filing date
TANGO THERAPEUTICS INC87583X109COM48,071$174,000thousands by filing date
SIRIUS XM HOLDINGS INC82968B103COM29,949$171,000thousands by filing date
ALDEYRA THERAPEUTICS INC01438T106COM31,813$170,000thousands by filing date
AFFIMED N VN01045108COM79,636$164,000thousands by filing date
WHITEHAWK THERAPEUTICS INC00032Q104CMN11,509$163,000thousands by filing date
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock20,144$160,000thousands by filing date
HOST HOTELS & RESORTS INC COM44107P104REIT10,019$159,000thousands by filing date
Arbutus Biopharma Corp03879J100Common Shares, without par value81,878$156,000thousands by filing date
VAXART INC NEW92243A200COM69,043$151,000thousands by filing date
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock17,663$142,000thousands by filing date
TRANSOCEAN LTD REGISTERED SHSH8817H100Stock51,337$127,000thousands by filing date
ZYNEX INC98986M103COM13,709$124,000thousands by filing date
LIANBIO ADR53000N108COM58,490$116,000thousands by filing date
SUNCOKE ENERGY INC86722A103COMMON STOCK19,704$114,000thousands by filing date
ARCHROCK INC03957W106COM17,621$113,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK94,343$111,000thousands by filing date
AUTOLUS THERAPEUTICS PLC SPON05280R100COM49,657$106,000thousands by filing date
CORECIVIC INC21871N101COM11,930$105,000thousands by filing date
KRONOS BIO INC50107A104COM31,034$104,000thousands by filing date
VBI VACCINES INC91822J103COM NEW140,981$100,000thousands by filing date
EVERQUOTE INC30041R108COM CL A14,186$97,000thousands by filing date
ADAPTIMMUNE THERAPEUTICS PLC00653A107SPONDS ADR88,339$95,000thousands by filing date
ACCO BRANDS CORP COM00081T108Stock15,633$77,000thousands by filing date
ICOSAVAX INC45114M109COM21,821$69,000thousands by filing date
JOUNCE THERAPEUTICS INC481116101COM28,212$66,000thousands by filing date
GRABHLDGSLTDFCLASSCLASSAG4124C109STOK20,645$54,000thousands by filing date
ESSA PHARMA INC29668H708COM NEW24,052$44,000thousands by filing date
SONDER HOLDINGS INC83542D102COM13,030$22,000thousands by filing date
SWVL HOLDINGS CORPG86302109CLASS A COM18,825$16,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001398344-22-021967this filing2022-11-14acceptance time not in the bulk data set